SB-001 Anti-COVID-19 mAb

SB-001
New Drug
SB-001 Anti-COVID-19 mAb

Indications:

COVID-19 (Severe Special Infectious Pneumonia)

  • Development progress

    1. Discovery

    2. Pre-clinical

    3. Phase I

    4. Phase II

SB-001

Indications

COVID-19 (Severe Special Infectious Pneumonia)

Development progress

Discovery Phase

Detail

AcadeMab has discovered a panel of fully human monoclonal antibodies (mAbs) directly against receptor binding domain (RBD) of SARS-CoV-2 spike (S) protein from SARS-CoV-2 vaccine recipients by human single B cell technology. One of the mAbs showed a comparable neutralization ability (IC50 = 11.4 and 4.3 ng/ml for Omicron variants BA.1 and BA.2, respectively) with the marketed mAbs. For Omicron BA.2, Bebtelovimab shows an IC50 value of 4.0 ng/ml and Evusheld reported IC50 ranging from 9.8 to 43 ng/ml. Furthermore, another hAb had broad-spectrum activity against multiple variants of concern (VOCs), including Delta variant and all tested Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 subvariants.
Notably, this panel of antibodies have strong binding activity to RBD and can cover the strains of wild type, Alpha, Beta, Kappa, Delta, Gamma, Omicron BA.1, BA.2, and BA.4/5 variants. These neutralizing human antibodies targeting the RBD domain of SARS-CoV-2 spike protein have potential in prophylactic or therapeutic applications for COVID-19.

 

BACK


Verification

Click the numbers in sequence.

academab.com may set and access academab.com cookies on your computer.  Cookies are used to provide our system with the basic information to provide the services you are requesting.  Cookies can be cleared at any time from your internet browser settings. 

 

Cookies Cookies

Privacy preference center

academab.com may set and access academab.com cookies on your computer.  Cookies are used to provide our system with the basic information to provide the services you are requesting.  Cookies can be cleared at any time from your internet browser settings. 

 

Privacy Privacy

Manage Consent Settings

Necessary Cookies

Enable All

網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作(即服務請求)來設置這些 Cookie,如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie,但可能會導致某些網站功能無法工作。